Lechner et al [316] evaluated 20 patients with primary colorectal cancer who were intravenously injected with 25 mCi (925 MBq) of 99Tc-anti-CEA monoclonal antibody fragment (99Tc-IMMU-4) on the day before RIGS. The gene discussed is CEACAM5; the disease is colorectal cancer.